Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-20
What changed in the last 30 days
4 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 2 with minor changes only.
- Minor: PPGR · Postprandial Glucose Levels, Gut Microbiota and Supplementation With Functional Foods in Adults Enrollment closed, study ongoing
- Minor: Personalized Nutrition Based on the Glycemic Response: Effect of Diet and Intestinal Microbiota Study completion pushed from Aug 30, 2025 to Dec 31, 2026
- Notable: ORReMex · Outcomes of Renal Replacement in Mexico Primary and study completion dates pushed to Dec 2029
- Notable: REMOV-HDx · Expanded Hemodialysis Versus High-Volume Online Hemodiafiltration for Uremic Toxin Removal Primary completion date changed from estimate of Apr 2026 to Nov 1, 2026
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-11-12 | NCT07930975 Lipid Management Gaps in Mexican Patients at High and Very High Cardiovascular Risk | Not Yet Recruiting |
Active trials by phase
| Phase 2 | 1 | |
| Phase 4 | 1 |
Not charted: 16 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials
Diabetes (6) · Type 2 Diabetes (5) · Obesity (3) · Chronic Kidney Disease (1) · Heart Disease (1) · Hypertension (1) · Pancreatic Cancer (1)
Get alerts when Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.